Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06841016 · ClinicalTrials.gov registry record · NA
Virtual Nephrologist
A NA study of Chronic Kidney Disease(CKD), sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
- 2
- Study locations
NCT06841016 is a NA study of Chronic Kidney Disease(CKD) that has completed, run by University of Pennsylvania. The registered enrollment target is 148 participants, below the 306-participant average among 5 other Chronic Kidney Disease(CKD) trials with a reported enrollment target (52% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06841016, a NA study of Chronic Kidney Disease(CKD), has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
- 2
- Study locations
Study Summary
To develop, pilot, and refine a virtual healthcare agent that will educate patients with advanced chronic kidney disease and their caregivers about kidney transplantation.
Conditions Studied
Interventions
- OTHER Virtual Nephrologist
Study Locations (2)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2024-03-26 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06841016
The ClinicalTrials.gov registry entry for NCT06841016 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 306-participant average among 5 other Chronic Kidney Disease(CKD) trials with a reported enrollment target (52% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Kidney Disease(CKD) appearing as the primary indexed condition, and to 1 intervention - of which Virtual Nephrologist is the first listed.
NCT06841016 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06841016 about?
NCT06841016 is a clinical study titled "Virtual Nephrologist". To develop, pilot, and refine a virtual healthcare agent that will educate patients with advanced chronic kidney disease and their caregivers about kidney transplantation.
What is the current status of trial NCT06841016?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2024-03-26. Estimated completion is 2025-12-31.
What conditions does trial NCT06841016 study?
This clinical trial studies the following conditions: Chronic Kidney Disease(CKD).
What interventions are being tested in trial NCT06841016?
The interventions under investigation include: Virtual Nephrologist (OTHER).
Who is sponsoring clinical trial NCT06841016?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06841016 being conducted?
This trial has 2 study locations across Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease(CKD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
RECRUITING · NA
-
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
RECRUITING · NA
-
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
RECRUITING · NA
-
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
RECRUITING
-
Kidney Function in People With Cystic Fibrosis in the Era of HEMT
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.